| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | May 16, 2025 | Longeveron Inc. | Chief Scientific Officer | Sell | 37.5 | -5,250 | -0.72% | ✗ | $7.4K |
| Apr 10, 2024 | Apr 12, 2024 | Longeveron Inc. | Chief Scientific Officer | Buy | 97.5 | +148,936 | 30.75% | ✗ | $350K |
| Jan 27, 2023 | Jan 30, 2023 | Longeveron Inc. | Chief Scientific Officer | Sell | 48.8 | -20,000 | -0.25% | ✓ | $85.6K |
| Dec 2, 2022 | Dec 5, 2022 | Longeveron Inc. | Chief Scientific Officer | Sell | 48.8 | -20,000 | -0.25% | ✓ | $74.8K |
| Oct 12, 2022 | Oct 18, 2022 | Longeveron Inc. | Chief Scientific Officer | Sell | 20.0 | -100,000 | -1.26% | ✗ | $361K |
| Apr 18, 2022 | Apr 20, 2022 | Longeveron Inc. | Chief Scientific Officer | Sell | 48.8 | -20,000 | -0.25% | ✓ | $200.1K |
| Oct 12, 2021 | Oct 14, 2021 | Longeveron Inc. | Chief Scientific Officer | Buy | 47.5 | +2,500 | 0.03% | ✗ | $9.2K |
| Oct 7, 2021 | Oct 12, 2021 | Longeveron Inc. | Chief Scientific Officer | Buy | 56.3 | +5,000 | 0.06% | ✗ | $16.9K |
| Feb 12, 2021 | Apr 9, 2021 | Longeveron Inc. | Chief Scientific Officer | Buy | 60.0 | +12,000 | 0.15% | ✗ | $120K |
| Feb 12, 2021 | Feb 17, 2021 | Longeveron Inc. | Chief Scientific Officer | Buy | 87.5 | +103,000 | 1.30% | ✗ | $1M |